A carregar...

EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β‐catenin at Ser552

Hepatocellular carcinoma (HCC) is one of the most common malignancies and the fourth leading cause of cancer‐related death worldwide. Our previous study showed that EYA4 functioned by suppressing growth of HCC tumor cells, but its molecular mechanism is still not elucidated. Based on the results of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Zhu, Xiao‐Xu, Li, Jian‐Hui, Cai, Jian‐Peng, Hou, Xun, Huang, Chen‐Song, Huang, Xi‐Tai, Wang, Jie‐Qin, Li, Shi‐Jin, Xu, Qiong‐Cong, Yin, Xiao‐Yu
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6778622/
https://ncbi.nlm.nih.gov/pubmed/31385398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14159
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!